LONDON (ShareCast) - (Sharecast News) - Barclays upgraded its stance on Chemring on Monday to 'overweight' from 'equalweight' and hiked the price target to 380p from 250p, saying it's the purest-play cyber exposure in its UK defence coverage.
It noted that Roke Manor currently represents 18% of FY20 revenues, 80% of which are cyber security versus the EU defence average of less than 10%, providing high end active cyber, cryptography, information warfare and consultancy.

"In our view, the business is well positioned competitively and it generates market-leading margins (around 25% versus peers less than 15%)," Barclays said. "We believe Chemring is the most attractive way to play the cyber security growth theme in the UK."

At 1140 GMT, the shares were up 3.2% at 309.50p.

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE